Search clinical trials for: Umbilical Cord Stem Cells Allogenic

Total 31679 results

Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

CD133+ Autologous Cells After Myocardial Infarction

Acute Myocardial Infarction

Italy
Morton Plant Mease Health Care
Ortho Biotech Products, L.P.

Terminated

Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer

Prostate Cancer

United States
German Heart Center

Unknown

Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery

Coronary Artery Bypass Graft Surgery | Aortic Valve Replacement | Bleeding and Cardiac Surgery | Allogeneic Blood Transfusion

Germany
Eunice Kennedy Shriver National Institute of Child...

Unknown

Effects of Spinal Cord Injury on Female Sexual Response

Multiple Sclerosis | Female Sexual Dysfunction | Spinal Cord Injury

United States
Pfizer

Completed

A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD

Pulmonary Disease, Chronic Obstructive

Australia, United Kingdom, Argentina, Germany, India
University of Glasgow

Unknown

Paraplegic Cycling: Improving Health After Spinal Cord Injury

Spinal Cord Injury

United Kingdom
Hospital Clinic of Barcelona

Terminated

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

HIV Infection

Spain
University of Saskatchewan
Saskatoon Health Region

Completed

The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.

Mood Disorders | Anxiety Disorders | Alcohol Abuse

Canada
University Health Network, Toronto
Organon

Completed

Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder

Depression | Excessive Daytime Sleepiness

Canada
University of Magdeburg

Unknown

Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma

Non-Hodgkin's Lymphoma

Germany
McGill University
Fonds de la Recherche en Santé du Québec

Completed

Study of Home-Based Exercise to Alleviate Postpartum Depression

Postpartum Depression

Canada
University Health Network, Toronto
The Litebook Company Ltd.

Completed

Exercise and Bright Light Treatment: Effects on Body Weight and Composition

Obesity | Fatigue

Canada
Bayside Health

Unknown

The Role of Naive T-Cells in HIV Pathogenesis

HIV Infections

Australia
Sheba Medical Center
National Alliance for Research on Schizophrenia and Depression

Unknown

Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized Trial

Dysthymic Disorder

Israel
Nordic Myeloma Study Group

Unknown

Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients

Multiple Myeloma

Denmark
The Alvin and Lois Lapidus Cancer Institute
Ortho Biotech Products, L.P.

Unknown

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Lymphoma, Non-Hodgkin | Diffuse Large B Cell Lymphoma

United States
Pfizer

Completed

The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD

Depressive Disorder, Major

United States
University of Bologna

Completed

Autologous Transplantation for Multiple Myeloma

Multiple Myeloma
Sunnybrook Health Sciences Centre

Withdrawn

Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents

Major Depression

Canada
Weill Medical College of Cornell University
Forest Laboratories

Terminated

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

Depression | Multiple Sclerosis

United States
The University of New South Wales
Ocean Nutrition; Your Health Inc.; Sphere Healthcare

Unknown

A Study of Omega-3 as a Treatment for Major Depression

Major Depression | Dysthymia

Australia
The University of New South Wales
Ocean Nutrition; Your Health Inc.; Sphere Healthcare

Unknown

A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression

Major Depression

Australia
Sanofi

Completed

XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

Colorectal Neoplasms | Colorectal Carcinoma | Metastases
University of Michigan Rogel Cancer Center
University of Michigan

Terminated

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

Metastatic Colorectal Cancer

United States
University Health Network, Toronto

Completed

Testosterone and Major Depression

Major Depression

Canada
University of Glasgow

Unknown

Exercise Testing During Treadmill Gait in Incomplete Spinal Cord Injury

Spinal Cord Injury

United Kingdom
Lymphoma Study Association

Completed

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma

B-Cell Lymphoma

France, Belgium, Switzerland
Memorial Sloan Kettering Cancer Center

Completed

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

Hematologic Malignancies | Streptococcal Sepsis

United States
University of North Carolina
Robert Wood Johnson Foundation

Completed

A Study of the Cost Effectiveness of Generalist Care Managers for Depression Treatment in Medicaid Recipients

Major Depressive Disorder

United States
Zhejiang University

Unknown

Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension

Idiopathic Pulmonary Arterial Hypertension

China
Finnish Institute for Health and Welfare
Finnish Foundation for Alcohol Studies

Completed

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

Depression | Alcoholism

Finland
Sheba Medical Center
H. Lundbeck A/S

Unknown

Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia

Depressive Syndrome

Israel
Sheba Medical Center

Unknown

TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis

Multiple Sclerosis

Israel
Julius-Maximilians University
University of Wuerzburg

Unknown

Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant

Leukemia | Medulloblastoma

Germany
National Center for Complementary and Integrative...

Completed

Qigong Therapy For Heart Device Patients

Depressive Disorder | Cardiac Diseases

United States
National Center for Complementary and Integrative...

Completed

Magnetic Stimulation for Parkinson Disease

Depression | Parkinson's Disease

United States
National Center for Complementary and Integrative...
National Cancer Institute (NCI)

Completed

The Effects of Music Therapy-Based Stress Reduction on Bone Marrow Transplant Recipients

Stem Cell Transplantation | Bone Marrow Transplantation

United States
National Center for Complementary and Integrative...
Office of Dietary Supplements (ODS)

Completed

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States
Laboratoires Thea

Completed

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

Keratoconjunctivitis, Vernal
Portland VA Medical Center
GlaxoSmithKline; Schering-Plough

Completed

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Major Depression
Tawam Hospital

Unknown

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

B-Cell Chronic Lymphocytic Leukemia
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

United States, Argentina, Poland, Romania, Turkey
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Depression | Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Major Depressive Disorder

United States

Search clinical trials for: Umbilical Cord Stem Cells Allogenic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations